首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1629326

神经血管栓塞设备市场，按产品、最终用途、国家和地区 - 2025-2032 年全球行业分析、市场规模、市场份额和预测

Neurovascular Embolization Devices Market, By Product, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: 2024年12月04日 | 出版商:

AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格

简介目录

报告要点

2024年神经血管栓塞设备市场规模为15.616亿美元，2025年至2032年复合年增长率为8.90%。

神经血管栓塞器材市场-市场动态

脑中风和动脉瘤病例增加

在整个预测期内，脑中风和动脉瘤病例数量的增加预计将推动全球神经血管栓塞设备市场的扩张。例如，世界中风组织声称，中风已经达到流行的程度。今年将有超过 1,220 万人首次中风，预计将有 650 万人因此死亡，这意味着四分之一的 25 岁以上成年人中就有 1 人会在一生中的某个阶段发生中风。在全球范围内，超过 1.1 亿人曾在一生中的某个时期患过中风。儘管中风的盛行率随着年龄的增长而急剧上升，但超过 60% 的中风发生在 70 岁以下的人群中，超过 16% 的中风发生在 50 岁以下的人群中。此外，英格兰国家医疗服务体系 (NHS England) 估计，每年英格兰每 12,500 人中就有 1 人患有脑动脉瘤破裂。此外，脑动脉瘤基金会估计，每年有超过 600 万美国人患有脑动脉瘤，英国有超过 3.0% 的人患有脑动脉瘤。此外，NIH报告称，全球范围内脑动脉瘤的盛行率约为3.2%，标准年龄为50岁，整体性别比例为1:1。 50 岁以后，这一比例变化很大，女性比例不断上升，接近 2:1。这被认为是因为循环雌激素水平较低导致血管组织的胶原蛋白范围减少。

神经血管栓塞设备市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2025-2032）每年将以 8.90% 左右的复合年增长率成长

根据产品细分，预计栓塞弹簧圈在 2024 年将占据最大市场份额

根据最终用途细分，到 2024 年，医院将成为领先类别

按地区划分，北美是 2024 年的主要收入来源

神经血管栓塞设备市场-細項分析：

全球神经血管栓塞设备市场根据产品、最终用途和地区进行细分。

依产品，市场分为液态栓塞剂、栓塞弹簧圈、动脉瘤夹、分流装置等。 2024 年，市场由栓塞弹簧圈类别主导。将称为栓塞弹簧圈的复杂铂装置插入动脉中以导致血栓形成。这些线圈成功地阻断了动脉瘤和其他血管异常，降低了破裂和随后出血的可能性。由于它们对各种解剖併发症的适应性，它们非常受欢迎。经过不断的研发努力，生物活性和可拆卸弹簧圈的开发提高了该领域的功效和安全性。此外，神经血管治疗中最重要的进展之一是液体栓塞的使用。

根据最终用途，市场分为医院、专科诊所和其他。 2024年，医院类别占据主导市场。医院因其先进的技术、庞大的基础设施和高素质的医务人员而成为神经血管栓塞等尖端医疗治疗的主要场所。凭藉最新的成像设备和介入套件，这些设施通常拥有专用的神经介入装置，可实现准确的诊断和客製化护理。在医院环境中，拥有合格的神经外科医生、介入放射科医生和神经科医生可以保证患有动脉瘤和动静脉畸形等疾病的患者得到全面的多学科护理。

神经血管栓塞设备市场-地理洞察

2024年，北美在全球神经血管栓塞器械市场占据主导地位。北美，尤其是美国和加拿大，神经血管栓塞装置的市场很大。这些国家的神经血管疾病发生率很高，医疗保健系统完善，医疗费用不断增加。政府措施和製造商研发 (R&D) 支出的增加对区域市场的成长产生了重大影响。此外，主要行业参与者推出新产品以使其产品线多样化，也有助于该行业的成长。例如，印度美敦力于2022年6月生产的第四代导流器Pipeline Vantage with Shield Technology，具有CE标誌，用于脑动脉瘤的血管内治疗。

然而，在整个预测期间，亚太地区预计复合年增长率最快。神经系统问题的日益普及、技术突破以及目标疾病负担的增加是造成这种情况的部分原因。主要参与者的存在和不断增长的医疗保健成本是推动该地区扩张的两个进一步因素。由于主要参与者的区域扩张以及亚太地区尚未开发的巨大前景，预计该市场在预测期内也将成长更快。该地区神经血管栓塞装置市场的三个最大供应商是中国、印度和日本。

神经血管栓塞设备市场-竞争格局：

神经血管栓塞装置领域的主要公司包括美敦力公司、史赛克公司、强生公司、B. Braun Melsungen AG.、Integra LifeSciences Corporation 等。神经血管栓塞装置的主要生产商正在集中精力进行併购，以使其产品线多样化。在医院和其他机构，企业正在举办会议和培训课程，向外科医生和从业人员介绍新型神经血管栓塞装置。此外，成长倡议，包括新产品发布、监管批准、扩张、伙伴关係、收购和合作，是主要业务的主要重点。例如，Terumo Corporation 旗下神经血管公司 MicroVention, Inc. 于 2023 年 7 月表示，其血管内装置 WEB 已发布 5 年监测资料。为了使动脉瘤栓塞技术更适应不同大小和类型的动脉瘤，他们还包括两种新尺寸（SL 7x2 和 SL 6x2）。该产品在圣地牙哥 SNIS 2023 的 615 号摊位展出。在整个预测期内，由于这些发展，对神经血管栓塞装置的需求将会增加。

近期发展

2023 年2 月：Shape Memory Medical Inc. 报告了第一例在德国接受治疗的患者，这是该公司即将对其用于外周血管栓塞的IMPEDE 和IMPEDE-FX 栓塞进行多中心登记调查的EMBO 后市场监测登记的一部分。

2022 年 7 月：在多伦多参加第 19 届神经介入外科学会 (SNIS) 年会时，设计创新神经血管设备的 Rapid Medical 公司获得了 FDA 510(k) 许可，将 TIGERTRIEVER 13 用于治疗大动脉闭塞。

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美神经血管栓塞装置主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按产品）
- 北美市场规模和预测（按最终用途）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲神经血管栓塞装置主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模和预测（按产品）
- 欧洲市场规模和预测（按最终用途）
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区神经血管栓塞器械主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按产品）
- 亚太地区市场规模和预测（按最终用途）
- 印度
- 中国
- 韩国
- 日本
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲神经血管栓塞装置主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按产品）
- 拉丁美洲市场规模和预测（按最终用途）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲神经血管栓塞装置主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按产品）
- 中东和非洲市场规模和预测（按最终用途）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 10 章：主要供应商分析 - 神经血管栓塞器械产业

竞争仪表板
公司简介
- Medtronic plc
- Stryker Corporation
- Johnson & Johnson Inc.
- B. Braun Melsungen AG.
- Integra LifeSciences Corporation
- Lepu Medical Technology (Beijing) Co.
- Terumo Corporation
- Acandis GmBH
- Phenox GmBH
- Shape Memory Medical Inc.
- Others

第 11 章：360 度分析师视角

第 12 章：附录

研究方法
参考
缩写
免责声明
联络我们

简介目录

Product Code: ANV4485

REPORT HIGHLIGHT

Neurovascular Embolization Devices Market size was valued at US$ 1,561.6 Million in 2024, expanding at a CAGR of 8.90% from 2025 to 2032.

Neurovascular embolization devices prevent or limit blood flow to unwanted vascular abnormalities. Neurovascular embolisation devices include aneurysm clips, liquid embolic systems, flow diversion stents, embolisation coils, and intravascular flow disruptors. A stroke occurs when the blood supply to the brain is disrupted, resulting in oxygen deprivation, brain damage, and diminished function. The most frequent cause is clots in the arteries that provide blood to the brain. Hemorrhage, which happens when blood seeps into the brain from a ruptured vessel, may even be the reason. Memory, cognitive, and linguistic issues, as well as partial paralysis, are among the long-term effects of a stroke. The increasing rates of brain stroke and aneurysms, the rise in product authorizations, the positive outcomes of research, market developments like mergers and acquisitions, the introduction of new products, and growing awareness are some of the factors that are expected to drive growth in the global market for neurovascular embolization devices over the forecast period. The growing number of cases and research funding are also expected to help the worldwide market's expansion over the course of the projected period.

Neurovascular Embolization Devices Market- Market Dynamics

Increased Brain Stroke and Aneurysm Cases

Throughout the forecast period, the rising number of brain stroke and aneurysm cases is anticipated to propel the expansion of the global neurovascular embolization devices market. The World Stroke Organization, for example, claims that epidemic proportions of stroke have already been reached. Over 12.2 million individuals are likely to have their first stroke this year, and 6.5 million are expected to die as a result, meaning that 1 in 4 adults over 25 will have a stroke at some point in their lives. Worldwide, more than 110 million people have had a stroke at some time in their life. Over 60% of strokes occur in those under 70, and over 16% occur in people under 50, despite the fact that the prevalence of stroke rises sharply with age. Additionally, NHS England estimates that 1 in 12,500 people in England suffer from a burst brain aneurysm annually. In addition, the Brain Aneurysm Foundation estimates that over 6.0 million Americans suffer from brain aneurysms each year, and over 3.0% of persons in the United Kingdom suffer from one. Moreover, the NIH reports that the prevalence of cerebral aneurysms is approximately 3.2% worldwide, with a standard age of 50 and a gender ratio of 1:1 overall. After age 50, this ratio varies significantly, with a growing female predominance that closes at 2:1. This is thought to be because lower levels of circulating estrogen cause the collagen range of the vascular tissue to diminish.

Neurovascular Embolization Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2025-2032)

Based on product segmentation, the embolic coils were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading category in 2024

On the basis of region, North America was the leading revenue generator in 2024

Neurovascular Embolization Devices Market- Segmentation Analysis:

The Global Neurovascular Embolization Devices Market is segmented on the basis of Product, End Use, and Region.

On the basis of product, the market is segregated into Liquid Embolic Agents, Embolic Coils, Aneurysm Clips, Flow Diversion Devices, and Others. In 2024, the market was dominated by the embolic coils category. Complex platinum devices called embolic coils are inserted into blood arteries to cause clots to form. These coils successfully block aneurysms and other vascular anomalies, lowering the possibility of rupture and ensuing bleeding. Because of their adaptability to a variety of anatomical complications, they are very popular. The development of bioactive and detachable coils has improved the field's efficacy and safety as a result of continuous research and development efforts. Furthermore, one of the most important developments in neurovascular treatments is the use of liquid emboli.

Based on end use, the market is divided into Hospitals, Specialty Clinics, and Others. In 2024, the hospitals category held a dominant market share. Hospitals are the main locations for cutting-edge medical treatments like neurovascular embolization because of their sophisticated technology, large infrastructure, and highly qualified medical personnel. With the newest imaging equipment and interventional suites, these facilities frequently have dedicated neuro interventional units that enable accurate diagnosis and customized care. In hospital settings, having qualified neurosurgeons, interventional radiologists, and neurologists guarantees patients with disorders like aneurysms and arteriovenous malformations full, multidisciplinary care.

Neurovascular Embolization Devices Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Neurovascular Embolization Devices. The market for neurovascular embolization devices is substantial in North America, particularly in the United States and Canada. These countries have high rates of neurovascular diseases, sophisticated healthcare systems, and growing medical expenses. The growth of the regional marketplace is significantly impacted by the heightened government initiatives and manufacturer research and development (R&D) spending. Additionally, the introduction of new products by major industry players to diversify their product lines contributes to the growth of the sector. For instance, India Medtronic's fourth-generation flow deflector, the Pipeline Vantage with Shield Technology, which has a CE mark, was created in June 2022 for endovascular treatment of cerebral aneurysms.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The increasing prevalence of neurological problems, technical breakthroughs, and the growing burden of target diseases are some of the causes of this. Key players' presence and growing healthcare costs are two further factors fueling the region's expansion. The market is also expected to grow more rapidly in the forecast period due to the regional expansion of major players and significant unexplored prospects in Asia Pacific. Three of the biggest suppliers to the neurovascular embolization device market in the area are China, India, and Japan.

Neurovascular Embolization Devices Market- Competitive Landscape:

Key companies in the neurovascular embolization devices are Medtronic plc, Stryker Corporation, Johnson & Johnson Inc., B. Braun Melsungen AG., Integra LifeSciences Corporation, and others. The primary producers of neurovascular embolization devices are concentrating on mergers and acquisitions in order to diversify their product lines. In hospitals and other institutions, businesses are holding conferences and training sessions to inform surgeons and practitioners about the new neurovascular embolization devices. Furthermore, growth initiatives, including new product releases, regulatory approvals, expansions, partnerships, acquisitions, and collaborations, are the main emphasis of the major businesses. For instance, MicroVention, Inc., a neurovascular company under Terumo Corporation, stated in July 2023 that its intravascular device, WEB, has released 5-year monitoring data. In order to make the Aneurysm Embolization Technology more adaptable to aneurysms of different sizes and types, they also included two new sizes (SL 7x2 and SL 6x2). The product is on display at Booth 615 at SNIS 2023 in San Diego. Throughout the projection period, the demand for neurovascular embolization devices will rise as a result of these developments.

Recent Development

February 2023: The first patient treated in Germany as part of the EMBO-Post Market Surveillance Registry, the company's upcoming multicenter registry investigation of its IMPEDE and IMPEDE-FX Embolization Plugs when used for peripheral vascular embolization, was reported by Shape Memory Medical Inc., a manufacturer of shape memory polymers for the peripheral and neurovascular markets.

July 2022: While attending the 19th Annual Conference of the Society of Neurointerventional Surgery (SNIS) in Toronto, Rapid Medical, a company that designs innovative neurovascular devices, received FDA 510(k) permission for TIGERTRIEVER 13 for major artery occlusions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Medtronic plc
Stryker Corporation
Johnson & Johnson Inc.
B. Braun Melsungen AG.
Integra LifeSciences Corporation
Lepu Medical Technology (Beijing) Co.
Terumo Corporation
Acandis GmBH
Phenox GmBH
Shape Memory Medical Inc.
Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Liquid Embolic Agents
Embolic Coils
Aneurysm Clips
Flow Diversion Devices
Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospitals
Specialty Clinics
Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Neurovascular Embolization Devices Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Neurovascular Embolization Devices Market Snippet by Product
- 2.1.2. Neurovascular Embolization Devices Market Snippet by End Use
- 2.1.3. Neurovascular Embolization Devices Market Snippet by Country
- 2.1.4. Neurovascular Embolization Devices Market Snippet by Region
2.2. Competitive Insights

3. Neurovascular Embolization Devices Key Market Trends

3.1. Neurovascular Embolization Devices Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Neurovascular Embolization Devices Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Neurovascular Embolization Devices Market Opportunities
3.4. Neurovascular Embolization Devices Market Future Trends

4. Neurovascular Embolization Devices Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Neurovascular Embolization Devices Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Neurovascular Embolization Devices Market Landscape

6.1. Neurovascular Embolization Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Neurovascular Embolization Devices Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Liquid Embolic Agents
- 7.1.3. Embolic Coils
- 7.1.4. Aneurysm Clips
- 7.1.5. Flow Diversion Devices
- 7.1.6. Others

8. Neurovascular Embolization Devices Market - By End Use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
- 8.1.2. Hospitals
- 8.1.3. Specialty Clinics
- 8.1.4. Others

9. Neurovascular Embolization Devices Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Neurovascular Embolization Devices Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Neurovascular Embolization Devices Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.7. France
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.8. Italy
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.9. Spain
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.10. United Kingdom
  - 9.3.10.1. Overview
  - 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.11. Russia
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.12. Netherlands
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.13. Sweden
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
  - 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
  - 9.3.15.1. Overview
  - 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Neurovascular Embolization Devices Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.8. South Korea
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.9. Japan
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Neurovascular Embolization Devices Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Neurovascular Embolization Devices Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Neurovascular Embolization Devices Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Medtronic plc
- 10.2.2. Stryker Corporation
- 10.2.3. Johnson & Johnson Inc.
- 10.2.4. B. Braun Melsungen AG.
- 10.2.5. Integra LifeSciences Corporation
- 10.2.6. Lepu Medical Technology (Beijing) Co.
- 10.2.7. Terumo Corporation
- 10.2.8. Acandis GmBH
- 10.2.9. Phenox GmBH
- 10.2.10. Shape Memory Medical Inc.
- 10.2.11. Others